CK Life Sciences Int'l., (Holdings) Inc. (stock code: 00775) released its monthly return on movements in securities for the period ended 28 February 2026. Authorized share capital remained at 15.00 billion ordinary shares with a par value of HKD 0.10 each, totaling HKD 1.50 billion.

Issued share capital stood unchanged at 9.61 billion ordinary shares, while the company confirmed compliance with its prescribed public float threshold of 25%. No changes in treasury shares or other equity movements were recorded during the period.